Earendil Labs starts phase 1 study of extended anti-TL1A antibody
11 Jul 2025 //
PR NEWSWIRE
Sanofi pens $1.8B deal for 2 autoimmune, immunology bispecifics
17 Apr 2025 //
FIERCE BIOTECH
11 Jul 2025 //
PR NEWSWIRE
17 Apr 2025 //
FIERCE BIOTECH